Tuesday, September 26, 2017 9:24:05 PM
* Can Climb much Higher !
________________________________________________________________
Trader53's Wealth Strategy:
Had you bought just 10 Million shares at 0.0002
for a Cost of just $2,000
your 10 Million shares could have been Sold
at a conservative 0.0020 for $20,000
on the climb to 0.0023
_________________________________________________________________
CWIR Security Details
Share Structure
Market Value1...........$1,563,354 a/o Sep 25, 2017
Authorized Shares..7,000,000,000 a/o Jul 20, 2016
Outstanding Shares 1,954,192,451 a/o Jul 20, 2016
Float..............1,086,949,892 a/o Jul 20, 2016
Par Value 0.001
Profile / News / Filings
http://www.otcmarkets.com/stock/CWIR/profile
News / Targets
http://www.allotcbb.com/quote.php?symbol=CWIR
https://www.barchart.com/stocks/quotes/CWIR
Time and Sales
http://www.investorpoint.com/stock/CWIR-Central+Wireless+Inc/price-history/
Analysis / Charts
http://www.stockscores.com/quickreport.asp?ticker=CWIR&x=0&y=0
________________________________________________________________
CWIR - Alerted at 0.0002
Climbs to 0.0023
Alerted
Friday, 08/11/17
CWIR 0.0002 - BUY
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=133756865
Alerted
Thursday, 08/10/17
CWIR 0.0002 - BUY
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=133734601
_________________________________________________________________
Embedded Charts
_________________________________________________________________
Live! Charts
FEATURED Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • BLOZF • May 7, 2024 8:51 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM